News | 03.29.20
Clopidogrel With Rivaroxaban and Aspirin Shows No Added Benefit After PAD Revascularization in VOYAGER PAD Subgroup Analysis
March 29, 2020—The American College of Cardiology (ACC) announced that results from a subgroup analysis of the VOYAGER PAD trial suggest that concomitant use of clopidogrel along with a regimen of rivaroxaban and aspirin provides no added benefit after revascularization for peripheral artery disease (PAD).
News | 03.28.20
VOYAGER PAD Evaluates Risk of Adverse Events With Rivaroxaban in Symptomatic PAD After Revascularization
March 28, 2020—At the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) held this year as a virtual conference, Marc P. Bonaca, MD, presented findings from the VOYAGER PAD study demonstrating that patients with symptomatic peripheral artery disease (PAD) who took rivaroxaban with aspirin after undergoing lower extremity revascularization had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
News | 03.12.20
Straub Medical Launches the Rotarex S Atherectomy Device in the United States
March 12, 2020—Straub Medical LLC, the United States direct-sales subsidiary of Switzerland-based Straub Medical AG, announced the launch and first intervention performed in the United States with the Rotarex S atherectomy device for treating occlusive peripheral vascular disease in both upper and lower extremity arteries.
News | 03.10.20
Prevalence and Predictors of Elevated Central Venous Pressure and Obstructive Sleep Apnea Evaluated in Patients With Lower Extremity Chronic Venous Disease
March 10, 2020—Online in Journal of Vascular Surgery: Venous & Lymphatic Disorders (JVS-VL) , Raghu Kolluri, MD, et al published findings from a study of the prevalence and predictors of elevated central venous pressure (CVP) and obstructive sleep apnea (OSA) in patients with lower extremity chronic venous disease (CVD).
News | 03.04.20
Multisociety 2020 Appropriate Use Criteria Address Chronic Lower Extremity Venous Disease
March 4, 2020—The 2020 appropriate use criteria (AUC) for chronic lower extremity venous disease were published by Elna Masuda, MD, et al online in Journal of Vascular Surgery (JVS): Venous and Lymphatic Disorders.
News | 02.27.20
Enrollment Begins in Pivotal Atherectomy Study of Ra Medical’s Dabra Excimer Laser System
February 27, 2020—Ra Medical Systems, Inc. announced enrollment of the first patient in a pivotal study to evaluate the safety and effectiveness of its Dabra excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses.
News | 02.24.20
Study Highlights Limitations of Resting ABI in the Diagnosis of Symptomatic PAD
February 24, 2020—The Society for Vascular Surgery (SVS) announced that findings from a large, single-center study highlight the limitations of using the resting ankle-brachial index (ABI) in the diagnosis of symptomatic peripheral arterial disease (PAD), particularly in those with diabetes mellitus (DM) and chronic kidney disease (CKD).
News | 02.21.20
No Mortality Difference Observed in JEVT Meta-Analysis of CLTI Patients Treated With Paclitaxel
February 21, 2020—Investigators seeking to explore the risks of paclitaxel-coated devices (PCDs) in patients with chronic limb-threatening ischemia (CLTI) have published a new meta-analysis finding no difference in short- to midterm mortality versus outcomes in patients treated with uncoated devices.
News | 02.20.20
Outcomes in Postpartum Women After CDT and Stenting for Iliofemoral DVT
February 20, 2020—The Society for Vascular Surgery (SVS) announced that findings from a single-center review of postpartum women undergoing catheter-directed thrombolysis (CDT) and stenting for acute iliofemoral deep vein thrombosis (DVT) may be more likely to experience stent occlusion and require reintervention.
News | 02.12.20
Study Reports Impact of Diabetes on 5-Year Outcomes After Endovascular Therapy for PAD
February 12, 2020—Findings from a study evaluating the long-term impact of diabetes mellitus in patients with peripheral artery disease (PAD) who underwent endovascular therapy were published by Michael S. Lee, MD, et al in Vascular Medicine (2020;25:33–40).
News | 02.10.20
One-Year Outcomes Published From CLI Substudy of LIBERTY 360º
February 10, 2020—One-year findings from a critical limb ischemia (CLI) subanalysis of the LIBERTY 360º study were published by Jihad A. Mustapha, MD, et al in Vascular Health and Risk Management, the official journal of the International Society of Vascular Health (2020;16:57–66). The study evaluated peripheral endovascular device intervention with any FDA-cleared device in CLI patients.
News | 02.06.20
Outcomes of Endovascular and Open Surgery Strategies Compared in Patients with Diabetic Foot Ulcer and PAD
February 6, 2020—Findings from a study comparing outcomes of endovascular surgery versus open vascular surgery in patients with diabetic foot ulcer (DFU) and peripheral artery disease (PAD) were published online ahead of print by Talha Butt, MD, et al in Journal of Diabetes and its Complications.
News | 01.30.20
Real-World Data Presented for VentureMed’s Flex Vessel Prep System to Treat Long CTOs
January 30, 2020—VentureMed Group, Inc. announced that data for the company’s Flex vessel preparation (VP) system were presented at ISET 2020, the International Symposium on Endovascular Therapy held January 22–25 in Hollywood, Florida.
News | 01.29.20
Interim Long-Term Safety Data Presented for BD’s Lutonix 014 DCB in BTK Arteries
January 29, 2020—BD (Becton, Dickinson and Company) announced the presentation of interim findings from the Lutonix BTK investigational device exemption trial of the company’s Lutonix 014 drug-coated balloon (DCB) versus standard balloon angioplasty for treatment of below-the-knee (BTK) arteries.
News | 01.28.20
One-Year TINTIN Data Presented for iVascular’s Luminor DCB and iVolution Stent
January 28, 2020—iVascular, based in Barcelona, Spain, announced that 1-year clinical outcomes of the TINTIN trial were presented by Principal Investigator Koen Deloose, MD, at LINC 2020, the Leipzig Interventional Course held January 28–31 in Leipzig, Germany.
News | 01.22.20
Systematic Review Supports Statin Therapy for Critical Limb Ischemia
January 22, 2020—Findings from a systematic review and meta-analysis evaluating the efficacy of statins in the critical limb ischemia (CLI) population were published online ahead of print by Damianos G. Kokkinidis, MD, et al in Vascular Medicine.
News | 01.21.20
Ra Medical Gains IDE to Conduct Pivotal Laser Atherectomy Trial of the DABRA System
January 21, 2020—Ra Medical Systems, Inc. announced approval from FDA that the company has provided sufficient data to support an investigational device exemption trial to evaluate the safety and effectiveness of the company’s DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.